Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Department of Physiology and Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Address correspondence to: Jahar Bhattacharya, Columbia University College of Physicians and Surgeons, Lung Biology Laboratory, Department of Medicine, 630 West 168th Street, BB 8-812, New York, New York 10032, USA. Phone: 212.305.7093; Fax: 212.305.6701; E-mail: firstname.lastname@example.org.
First published October 24, 2012 - More info
See the related article beginning on page 4218.
When ventilation is blocked, the lung can protect against the loss of blood oxygenation by activating localized arterial vasoconstriction, reducing blood flow to underventilated regions, and redirecting flow to better-ventilated alveoli. This phenomenon, hypoxic pulmonary vasoconstriction (HPV), preserves the overall efficiency of blood oxygenation, but the mechanism by which the hypoxic signal is transmitted to the smooth muscle that contracts the arterioles has remained largely a mystery. In this issue of the JCI, Wang et al. reveal that the endothelial lining of the hypoxic alveoli plays a key role in sensing hypoxia and transmitting the signal to initiate HPV.
The equilibrium between ventilation to a lung region and the region’s blood supply establishes blood oxygenation, the critical physiological outcome that ensures oxygen delivery to tissues. Multiple lung diseases threaten this equilibrium, potentially increasing the risk of systemic hypoxia. Hypoxic venous blood returning to the lungs gets oxygenated as it flows through alveolar capillaries, where oxygen diffuses into it from alveoli. Diseases that impair alveolar ventilation also impair blood oxygenation. This occurs, for example, in lung injury in which alveoli are inundated with plasma exudate and inflammatory cells and can therefore no longer be ventilated. Hypoxic blood streaming from diseased regions mixes with oxygenated blood streaming from well-ventilated regions. The admixture of the hypoxic streams potentially causes hypoxemia of the entire pulmonary outflow destined for systemic vascular beds. The lung protects against systemic hypoxemia by activating localized arterial vasoconstriction, which effectively turns off blood flow to underventilated regions, redirecting flow to better-ventilated alveoli and thereby restricting the formation of hypoxic streams. This phenomenon, commonly called hypoxic pulmonary vasoconstriction (HPV), preserves the overall efficacy of blood oxygenation. As Sylvester et al. discuss in a recent review (1), HPV has been long recognized, but is not entirely understood at the mechanistic level.
In moderate hypoxia, defined as a fall in the oxygen tension of alveolar gas to 30–50 mmHg, HPV is seen within minutes, which indicates that the hypoxic signal rapidly traverses the spatial separation between the alveoli and the upstream arteriolar segment, the site of vasoconstriction. Since smooth muscle contraction is required for HPV, the bulk of the research in the field has focused on mechanisms of smooth muscle contractility. In general, these mechanisms are based on the notion that hypoxia of pulmonary arterial smooth muscle decreases mitochondrial oxidative phosphorylation, leading to contractility-inducing events such as K+ channel closure and cytosolic Ca2+ increase (1). Since these mechanisms are evidently activated after the smooth muscle has already been exposed to hypoxia, it remains unclear how hypoxia itself, or a signal induced by hypoxia, is conveyed from underventilated, hypoxic alveoli to upstream arterioles.
One possibility is that the signal passes by direct diffusion. Weibel proposed that oxygen diffusion could occur from alveoli to all surrounding tissues (2). Jameson confirmed this prediction, showing that when alveoli are hyperoxic, as during pure oxygen breathing, oxygen diffuses to pulmonary arteries (3). However, the picture is different for normoxic alveoli. In their classic paper, Conhaim and Staub determined the extent to which precapillary blood undergoes oxygenation at different levels of alveolar oxygen tension, thereby reflecting the extent of oxygen diffusion from alveoli to the arteriolar segment (4). Although their findings for high oxygen breathing agree with Jameson’s interpretation that alveolar hyperoxia is capable of driving oxygen diffusion to the arterioles, their critical finding was that the diffusion is limited when alveoli are normoxic. Hence, it is unlikely that significant diffusion to the arterioles occurs when the alveoli are hypoxic, when the alveolus-arteriole oxygen gradient is probably even smaller than in normoxia, leaving open the question of how the arteriolar smooth muscle senses alveolar hypoxia.
In this issue of the JCI, the paper by Wang et al. from the Kuebler group reports a remarkably elegant solution to this longstanding puzzle (5). The authors found that the alveolar capillary endothelium plays a primary role in sensing alveolar hypoxia as well as in providing a conduit for signals that alert upstream arterioles to the hypoxia. The hypoxia sensing takes place in alveolar capillaries as a consequence of hypoxia-induced endothelial K+ channel closure, which leads to endothelial membrane depolarization and Ca2+ entry. The conduit for signal transmission is provided by endothelial gap junctional communication, in which the Ca2+ increase passes from the alveolar to the upstream arteriolar endothelium. Arteriolar constriction ensues as the Ca2+-activated arteriolar endothelium induces paracrine stimulation of the surrounding smooth muscle (Figure 1).
Essential features of the capillary mechanism of HPV. Mixed venous blood flows in through the pulmonary artery that branches to arterioles and then alveolar capillaries. The vascular smooth muscle investment ends at the level of the arterioles. The capillaries surround the air-filled alveolus. (A) In the normally ventilated alveolus, the hypoxic blood (blue) becomes oxygenated (red) and leaves the lung through the pulmonary veins. (B) Blockade of ventilation by airway disease causes alveolar hypoxia. The capillary endothelium is depolarized. The resulting increase of endothelial Ca2+ is communicated through endothelial gap junctions to smooth muscle surrounding upstream arterioles. Smooth muscle activation causes arteriolar constriction, restricting blood flow in the underventilated region.
The beauty of this proposal is that it is completely out of the box. For the first time, it places the first-alert warning system for hypoxia at the primary site of blood oxygenation, namely the alveoli. The capillary endothelium is clearly well positioned in this regard, since the endothelial membrane lies immediately adjacent to the alveolar epithelial membrane. This double membrane is in places only fractions of a micron thick and is therefore exquisitely engineered for rapid oxygen diffusion. These features ensure an agile hypoxia-sensing system that would probably not be surpassed were the sensing sites to lie further from the alveoli.
This proposal from Wang et al. also brings into focus the increasing understanding that the intercellular connectivity of lung microvessels determines pathophysiological responses in the lung. The lung microvascular endothelium richly expresses several connexins, the constitutive components of intercellular gap junctional channels. The lung’s endothelial lining, formed by gap junction–connected endothelial cells, is in fact a syncytium that can rapidly transmit diffusible signals across relatively large distances of the vascular bed. Previous work has shown that this syncytium is important for the spread of signals that amplify the lung’s immune response to injurious agents (6). Now, Wang et al. show that the endothelial syncytium transmits hypoxia-generated signals from the alveoli to the arterioles (5). In this case, the endothelial syncytium provides a high-speed throughway that rapidly conveys early warning signals to activate the defensive HPV response.
When could this elegant hypoxia-alert mechanism fail? Wang et al. suggest one potential scenario, namely during severe hypoxia. They found that when alveolar hypoxia is sufficiently intense as to decrease the blood oxygen tension to well below 30 mmHg, the endothelial depolarization that is critical to the hypoxia alert does not occur. Consequently, there is no increase in endothelial Ca2+ and, presumably, no transmission of any Ca2+-dependent warning signals to arteriolar vessels through endothelial gap junctions. A similar failure of capillary signaling could occur in conditions such as lung injury if there is endothelial damage, causing loss of endothelial gap junctional communication. Acute lung inflammation decreases lung expression of connexin 40 (7), the same connexin that alerts arterioles to alveolar hypoxia (5). In fact, the finding that HPV is abrogated in connexin 40–knockout mice (5) suggests that in lung injury, loss of signaling through endothelial gap junctions might contribute to HPV failure, and hence hypoxemia severity, in this condition.
The larger significance of these findings in lung vascular biology might relate to other capillary responses that are reported to occur after activation of voltage-dependent Ca2+ channels. Stoppage of lung blood flow causes endothelial membrane depolarization in lung capillaries, leading to endothelial Ca2+ entry through the voltage-dependent Ca2+ channel α1G — the same channel studied by Wang et al. — to cause release of reactive oxygen species through NADPH oxidase induction (8). The PAR-1 activator thrombin also induces endothelial Ca2+ entry through the α1G channel to activate endothelial expression of the leukocyte adhesion receptor P-selectin in alveolar capillaries (9). Taking these diverse findings together, it would seem that voltage-activated Ca2+ entry forms a fulcrum for multiple lung vascular phenomena that could potentially coalesce into a pathogenic process. Clearly, more needs to be known as to how voltage-dependent Ca2+ entry in lung endothelium co-opts gap junctional communication to promote vascular diseases of the lung. Nevertheless, the mechanisms of hypoxia sensing now identified by Wang et al. open up possibilities for targeting voltage-gated channels and gap junctional proteins in the therapy of diseases in which loss of the protection by HPV is a known adverse factor.
The author acknowledges Sunita Bhattacharya and Mallar Bhattacharya for reading the manuscript. J. Bhattacharya is supported by NIH grants HL36024 and HL64896.
Conflict of interest: The author has declared that no conflict of interest exists.
Citation for this article:J Clin Invest. 2012;122(11):3845–3847. doi:10.1172/JCI65623.
See the related article beginning on page 4218.
Copyright © 2015 American Society for Clinical Investigation